UK market developments: GHO Capital invests in RoslinCT, Symbiosis expands viral therapy capabilities 11-Jan-2022 By Jane Byrne Healthcare investors, GHO Capital Partners LLP, have invested in Scotland based, RoslinCT, a contract development and manufacturing organization (CDMO) focused on advanced cell therapies.